文献速递质量管理与危急值临床免疫

欧洲生物学变异数据联合Westgard Sigma规则在室内质控中的实际应用

Practical application of European biological variation combined with Westgard Sigma Rules in internal quality control.
PubMed 文献 · Clin Chem Lab Med · 2022-08-29

本研究利用室内质控数据计算精密度、室间质评偏差计算偏倚,以欧洲临床化学与检验医学联合会生物学变异数据推导肿瘤标志物允许总误差,并基于Sigma度量按Westgard Sigma规则制定各肿瘤标志物的室内质控策略。结果显示Sigma度量随允许总误差水平变化,以最低允许总误差为质量目标时除神经元特异性烯醇化酶外多数肿瘤标志物达到3σ或更优。

要点

  • 以EFLM生物学变异数据推导肿瘤标志物允许总误差并计算Sigma度量。
  • Sigma度量随允许总误差水平变化,质量目标选择直接影响质控策略。
  • 以最低允许总误差为目标时多数肿瘤标志物Sigma值达3σ或更优。

核心结论

  • 基于欧洲生物学变异数据库的质量目标联合Westgard Sigma规则可用于制定肿瘤标志物的室内质控策略。

研究设计与样本

  • 研究以室内质控数据计算精密度,以室间质评组均值与实验室测定值的相对偏差计算偏倚,以EFLM生物学变异数据推导允许总误差。
  • 在计算Sigma度量后,按Westgard Sigma规则确定每种肿瘤标志物的室内质控策略。

主要发现

  • 每种分析物的Sigma度量随允许总误差水平变化。
  • 以最低允许总误差为质量目标时,除神经元特异性烯醇化酶外多数肿瘤标志物达到3σ或更优。
  • 以期望允许总误差和最佳允许总误差为质量目标时,几乎所有分析物的Sigma值低于3。
  • 以最低允许总误差为质量目标时,每种分析物按Sigma值匹配相应的室内质控多规则和质控测定次数。

关键数值与推荐

  • 以最低允许总误差为质量目标时,除神经元特异性烯醇化酶外多数肿瘤标志物达到3σ或更优。
  • 以期望允许总误差和最佳允许总误差为质量目标时,几乎所有分析物Sigma值低于3。

临床怎么用

  • 检验科可基于EFLM生物学变异数据设定肿瘤标志物允许总误差,并计算Sigma度量以选择室内质控规则和质控测定次数。
  • 质量目标的选择应结合实验室可接受的允许总误差水平,因其直接影响Sigma度量与质控策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Westgard Sigma Rules is a statistical tool available for quality control. Biological variation (BV) can be used to set analytical performance specifications (APS). The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) regularly updates BV data. However, few studies have used robust BV data to determine quality goals and design a quality control strategy for tumor markers. The aim of this study was to derive APS for tumor markers from EFLM BV data and apply Westgard Sigma Rules to establish internal quality control (IQC) rules. METHODS: Precision was calculated from IQC data, and bias was obtained from the relative deviation of the External quality assurance scheme (EQAS) group mean values and laboratory-measured values. Total allowable error (TEa) was derived using EFLM BV data. After calculating sigma metrics, the IQC strategy for each tumor marker was determined according to Westgard Sigma Rules. RESULTS: Sigma metrics achieved for each analyte varied with the level of TEa. Most of these tumor markers except neuron-specific enolase reached 3σ or better based on TEamin. With TEades and TEaopt set as the quality goals, almost all analytes had sigma values below 3. Set TEamin as quality goal, each analyte matched IQC muti rules and numbers of control measurements according to sigma values. CONCLUSIONS: Quality goals from the EFLM BV database and Westgard Sigma Rules can be used to develop IQC strategy for tumor markers.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Song Z, Zhang J, Liu B, et al. Practical application of European biological variation combined with Westgard Sigma Rules in internal quality control. Clin Chem Lab Med. 2022. PMID: 36036501. doi:10.1515/cclm-2022-0327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。